PL1773307T3 - Preparaty 2-amino-1,3-propanodioli i ich analogów - Google Patents

Preparaty 2-amino-1,3-propanodioli i ich analogów

Info

Publication number
PL1773307T3
PL1773307T3 PL05768530T PL05768530T PL1773307T3 PL 1773307 T3 PL1773307 T3 PL 1773307T3 PL 05768530 T PL05768530 T PL 05768530T PL 05768530 T PL05768530 T PL 05768530T PL 1773307 T3 PL1773307 T3 PL 1773307T3
Authority
PL
Poland
Prior art keywords
amino
compound formulations
propanediol compounds
propanediol
compounds
Prior art date
Application number
PL05768530T
Other languages
English (en)
Inventor
Thitiwan Buranachokpaisan
Rose-Marie Dannenfelser
Ping Li
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL1773307T3 publication Critical patent/PL1773307T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL05768530T 2004-07-30 2005-07-29 Preparaty 2-amino-1,3-propanodioli i ich analogów PL1773307T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59299104P 2004-07-30 2004-07-30
EP05768530.7A EP1773307B8 (en) 2004-07-30 2005-07-29 Compound formulations of 2-amino-1,3-propanediol compounds
PCT/EP2005/008267 WO2006010630A1 (en) 2004-07-30 2005-07-29 Compound formulations of 2-amino-1, 3-propanediol compounds

Publications (1)

Publication Number Publication Date
PL1773307T3 true PL1773307T3 (pl) 2015-03-31

Family

ID=35058068

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05768530T PL1773307T3 (pl) 2004-07-30 2005-07-29 Preparaty 2-amino-1,3-propanodioli i ich analogów

Country Status (14)

Country Link
US (3) US20080096972A1 (pl)
EP (2) EP1773307B8 (pl)
JP (1) JP5214966B2 (pl)
KR (1) KR101174930B1 (pl)
CN (1) CN1993115B (pl)
AU (2) AU2005266449B2 (pl)
BR (1) BRPI0513935A (pl)
CA (1) CA2574664C (pl)
ES (1) ES2527055T3 (pl)
MX (1) MX2007001236A (pl)
PL (1) PL1773307T3 (pl)
PT (1) PT1773307E (pl)
RU (2) RU2402324C2 (pl)
WO (1) WO2006010630A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080096972A1 (en) * 2004-07-30 2008-04-24 Thitiwan Buranachokpaisan Compound formulations of 2-amino-1, 3-propanediol compounds
AU2013100532B4 (en) * 2008-11-11 2013-11-28 Novartis Ag Crystalline forms of fingolimod HCL
AU2010217605B2 (en) * 2009-02-24 2012-07-26 Novartis Ag Ceramide-analogous metabolites
RU2496486C1 (ru) 2012-07-11 2013-10-27 Александр Васильевич Иващенко Фармацевтическая композиция с улучшенной сыпучестью, лекарственное средство, способ получения и применение
RU2530532C1 (ru) * 2013-03-26 2014-10-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования Национальный исследовательский ядерный университет "МИФИ" (НИЯУ МИФИ) Устройство плавного пуска асинхронного двигателя
US20160128951A1 (en) 2013-07-29 2016-05-12 Aizant Drug Research Solutions Pvt Ltd Pharmaceutical compositions of fingolimod
CN103724215A (zh) * 2013-11-28 2014-04-16 镇江圣安医药有限公司 2-氨基-2-[2-(4-辛基苯基)乙基]-1,3-丙二醇的新型衍生物及其应用
WO2016042493A1 (en) 2014-09-19 2016-03-24 Aizant Drug Research Pvt. Ltd Pharmaceutical compositions of fingolimod

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985004580A1 (en) * 1984-04-09 1985-10-24 American Hospital Supply Corporation Pharmaceutical composition and method for treatment or prophylaxis of cardiac disorders
US5223515A (en) * 1988-08-18 1993-06-29 Takeda Chemical Industries, Ltd. Injectable solution containing a pyridyl methylsulfinylbenzimidazole
JP2536173B2 (ja) * 1988-08-18 1996-09-18 武田薬品工業株式会社 注射剤
AU6001790A (en) * 1989-08-02 1991-02-07 Warner-Lambert Company Formulations of phenytoin sodium for intravenous administration
WO1994008943A1 (fr) * 1992-10-21 1994-04-28 Yoshitomi Pharmaceutical Industries, Ltd. Compose 2-amino-1,3-propanediol et immunosuppresseur
US5616588A (en) * 1993-09-30 1997-04-01 American Home Products Corporation Rapamycin formulation for IV injection
IL111008A (en) * 1993-09-30 1999-10-28 American Home Prod Rapamycin formulations for intravenous injection and their preparation
ATE211726T1 (de) 1994-08-22 2002-01-15 Welfide Corp Benzolderivate und deren medizinische verwendung
HU224814B1 (en) * 1995-12-28 2006-02-28 Mitsubishi Pharma Corp Use of propane-1,3-diol derivative for the preparation of a medicament useful for the topical treating of inflammatory and immune diseases
JPH11209277A (ja) * 1998-01-19 1999-08-03 Yoshitomi Pharmaceut Ind Ltd 医薬組成物
US6476004B1 (en) 1996-07-18 2002-11-05 Mitsubishi Pharma Corporation Pharmaceutical composition
GB9624038D0 (en) * 1996-11-19 1997-01-08 Sandoz Ltd Organic compounds
KR20000075745A (ko) * 1997-02-27 2000-12-26 가마후라 아키오 의약 조성물
USRE39072E1 (en) 1997-04-04 2006-04-18 Mitsubishi Pharma Corporation 2-aminopropane-1,3-diol compounds, medicinal use thereof, and intermediates in synthesizing the same
ES2237970T3 (es) 1998-11-11 2005-08-01 Novartis Ag Produccion de 2-amino-2-(2-(4-alquil c2-20-fenil)etil)propano-1,3-dioles.
WO2001003739A1 (fr) * 1999-07-12 2001-01-18 Ono Pharmaceutical Co., Ltd. Inhibiteurs de fibrose contenant comme ingredient actif l'agoniste du recepteur de sphingosine-1-phosphate ou la sphingosine-1-phosphate
EP1300405B1 (en) 2000-07-13 2007-04-18 Sankyo Company, Limited Amino alcohol derivatives
EP1315735A4 (en) * 2000-08-31 2005-04-06 Merck & Co Inc Phosphate derivatives as immunoregulatory compounds
MXPA03008755A (es) 2001-03-26 2004-02-18 Novartis Ag Derivados de 2-amino-propanol.
JP2002316985A (ja) 2001-04-20 2002-10-31 Sankyo Co Ltd ベンゾチオフェン誘導体
CA2461212C (en) 2001-09-27 2010-08-17 Kyorin Pharmaceutical Co., Ltd. Diaryl sulfide derivatives, salts thereof and immunosuppressive agents using the same
DE60235900D1 (de) 2001-09-27 2010-05-20 Kyorin Seiyaku Kk Osuppressivum
ATE441654T1 (de) * 2002-01-18 2009-09-15 Merck & Co Inc Edg-rezeptoragonisten
AU2003202994B2 (en) * 2002-01-18 2007-11-22 Merck Sharp & Dohme Corp. N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonists
DE10226255A1 (de) 2002-06-13 2003-12-24 Bosch Gmbh Robert Schutzvorrichtung
BRPI0409250B8 (pt) * 2003-04-08 2022-01-18 Mitsubishi Pharma Corp Composições farmacêuticas sólidas compreendendo um agonista receptor de s1p e um álcool do açúcar
US20080096972A1 (en) * 2004-07-30 2008-04-24 Thitiwan Buranachokpaisan Compound formulations of 2-amino-1, 3-propanediol compounds

Also Published As

Publication number Publication date
AU2005266449B2 (en) 2009-10-08
JP2008508222A (ja) 2008-03-21
RU2468793C2 (ru) 2012-12-10
CN1993115A (zh) 2007-07-04
JP5214966B2 (ja) 2013-06-19
KR101174930B1 (ko) 2012-08-17
CA2574664C (en) 2013-01-15
RU2010124600A (ru) 2011-12-27
CA2574664A1 (en) 2006-02-02
RU2402324C2 (ru) 2010-10-27
MX2007001236A (es) 2007-03-23
RU2007107171A (ru) 2008-09-10
AU2009217456A1 (en) 2009-10-15
AU2005266449A1 (en) 2006-02-02
US20160101179A1 (en) 2016-04-14
BRPI0513935A (pt) 2008-05-20
PT1773307E (pt) 2015-01-14
US20140094522A1 (en) 2014-04-03
KR20070042988A (ko) 2007-04-24
CN1993115B (zh) 2011-12-28
EP1773307A1 (en) 2007-04-18
ES2527055T3 (es) 2015-01-20
EP1773307B1 (en) 2014-10-15
EP1773307B8 (en) 2014-12-17
EP2829268A1 (en) 2015-01-28
US20080096972A1 (en) 2008-04-24
WO2006010630A1 (en) 2006-02-02

Similar Documents

Publication Publication Date Title
IL178969A0 (en) Fungicidal mixtures of amidinylphenyl compounds
IL177424A0 (en) Galenic formulations of organic compounds
IL206109A (en) Cinnamide compound
SI1710241T1 (sl) Intermediatne spojine za pripravo trans-5-kloro-2-metil-2,3,3a, 12b-tetrahidro-1H-dibenz(2,3:6,7)oksepino(4,5-C)pirola
EP1718638A4 (en) NEW COMPOUNDS
ZA200705011B (en) Formulations of substituted benzoxazoles
SI1932522T1 (sl) Terapevtsko sredstvo za jetrno bolezen, ki vsebuje 2-amino-1,3- propandiolni derivat kot aktivno sestavino
PL1801108T3 (pl) Związki morfolinowe do leczenia stanów zapalnych
IL177315A0 (en) Process for the preparation of substituted triazole compounds
PL1773307T3 (pl) Preparaty 2-amino-1,3-propanodioli i ich analogów
GB0427403D0 (en) Novel compounds I
HUE031355T2 (hu) Vízben nem oldódó aktív szerves vegyületek kompozíciói
EP1796793A4 (en) NEW CONNECTIONS
ZA200609845B (en) Cinnamide compound
PL1623977T3 (pl) Związek pośredni stosowany do wytwarzania pioglitazonu
CL2004001156A1 (es) Procedimiento de preparacion de compuestos heterociclicos.
IL178960A0 (en) Process for the preparation of pyridin-2-ylmethylsulphinyl-1h-benzimidazol compounds
ZA200607540B (en) Process for the preparation of substituted triazole compounds
HK1098693A (zh) 有机化合物的盖仑制剂配方
GB0417903D0 (en) Hard setting compound
SI1623977T1 (sl) Vmesna spojina, ki se uporablja za pripravo pioglitazona
HK1110525A (en) Formulations of substituted benzoxazoles
GB0412550D0 (en) Novel compound
GB0413367D0 (en) Novel compound
GB0413758D0 (en) Novel compound